Jun 11, 2025, 13:51 | Insight

Naveen Pemmaraju Shared 2025 Leukemia Review on Epigenetic Therapies in Myeloid Cancers

Naveen Pemmaraju, Professor at the Department of Leukemia of MD Anderson Cancer Center, shared a…

Jun 11, 2025, 05:35 | Opinion

Naveen Pemmaraju: Wonderful to honor our amazing fellows

Naveen Pemmaraju, Professor at the Department of Leukemia of MD Anderson Cancer Center, shared on…

Jun 6, 2025, 09:37 | Blog

Naveen Pemmaraju: Leukemia Dream Team

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University…

May 30, 2025, 09:10 | Blog

Dean Crowe: You Never Forget The War You Waged With Childhood Cancer

Dean Crowe, Founder and CEO of the Rally Foundation for Childhood Cancer Research , shared…

May 29, 2025, 12:46 | Blog

Honoring World Blood Cancer Day 2025: A Global Call to Action and Hope

On World Blood Cancer Day (WBCD), observed annually on May 28, the global oncology community…

May 24, 2025, 13:11 | Blog

Oscar Borja Montes: Gender Disparity in Enrollment in Clinical Trials for Hairy Cell Leukemia Treatments

Oscar Borja Montes, Hem/Onc Fellow at the University of Florida, posted on X: "Why is…

May 23, 2025, 17:16 | Insight

Thomas George on the Connection Between Leukemia and Taurine - UF Health Cancer Center

UF Health Cancer Center shared a post on LinkedIn: "A new study published in Nature…

May 21, 2025, 12:50 | Blog

Ahmed Magdy Rabea: Practical Guidance on the Clinical Management of Belantamab Mafodotin for Patients with Relapsed/Refractory Multiple Myeloma

Ahmed Magdy Rabea, Head of Medical Oncology Department at Shifa Hospital, shared a post on LinkedIn:…

May 19, 2025, 22:47 | Blog

Chris Boshoff: Pfizer Continues to Lead in Antibody-Drug Conjugate Innovation

Chris Boshoff, Chief Scientific Officer and President of Research and Development at Pfizer, shared a…

May 18, 2025, 15:48 | Insight

A Common Ingredient in Energy Drinks – Taurine – Accelerates the Progression of Leukemia - NFCR

National Foundation for Cancer Research shared a post on LinkedIn: "New research alert: A common…

May 18, 2025, 12:23 | Science

Naveen Pemmaraju: The Evolving Landscape of Epigenetic Target Molecules and Therapies in Myeloid Cancers

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…

May 18, 2025, 09:54 | Opinion

Ashraf Saad: Fenretinide Induces Cytotoxicity in GATA1+ Erythroid and Megakaryoblastic Leukemia

Ashraf Saad, pediatric hematologist, posted on X: ""Here, we identify the small molecule (4-HPR, Fenretinide)…

May 9, 2025, 17:23 | Blog

Jan-Henning Klusmann: RNA Innovation in Focus – Retreat of the DFG Research Unit RU5433

Jan-Henning Klusmann, Professor of Pediatrics at the Goethe University Frankfurt, shared a post on LinkedIn:…

May 4, 2025, 17:38 | Insight

Naveen Pemmaraju joined expert panel on myeloproliferative neoplasms at the Think Tank25 Meeting

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…

May 2, 2025, 20:26 | Insight

Susanna Fletcher Greer: A V Foundation Researcher May Have Found the End-all to B-ALL

Susanna Fletcher Greer, Chief Scientific Officer of the V Foundation, shared a post on LinkedIn:…

May 2, 2025, 11:23 | Blog

Sanam Loghavi: Hemepath Morphology Challenge

Sanam Loghavi, Associate Professor of Pathology at MD Anderson Cancer Center, posted on X: "Hemepath…

Apr 28, 2025, 13:05 | Blog

Kristen Dahlgren: Cancer Research at a Crossroads, Sustaining Progress Against Cancer for the Benefit of Patients

Kristen Dahlgren, Founder and CEO at Cancer Vaccine Coalition, shared a post on LinkedIn: "Never…

Apr 27, 2025, 11:12 | Blog

4th Biennial Miami Leukemia Symposium commences with opening remarks from Mikkael A. Sekeres - Sylvester Comprehensive Cancer Center

Sylvester Comprehensive Cancer Center shared a post on X: “We kicked off our 4th Biennial Miami…

Apr 27, 2025, 10:36 | Blog

Shaping the future of leukemia research at 4th Biennial Miami Leukemia Symposium - Sylvester Comprehensive Cancer Center

Sylvester Comprehensive Cancer Center shared a post on X: "Our incredible co-directors: Justin Watts, Dr. Maria…

Apr 26, 2025, 18:35 | Science

James Fan Wu: National cancer system metrics and leukemia outcomes

James Fan Wu, Hematology/Oncology Fellow at Medical College of Wisconsin, posted on LinkedIn, about recent…

Apr 18, 2025, 02:31 | Blog

Loizos G. Loizou: A run of solidarity and compassion for all the children battling cancer and leukemia

Loizos G. Loizou, SIOP Europe Ambassador for Children with Cancer, Professor at Medical School of University…

Apr 15, 2025, 15:26 | Science

Miguel Bronchud: How to Sequence Therapies in a Patient With Relapsed CLL

Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared an article by Neil E Kay, et…

Apr 15, 2025, 01:45 | Insight

Susanna Fletcher Greer: 7 reasons why collaboration between our grantees leads to something greater for ALL patients

Susanna Fletcher Greer, Chief Scientific Officer of the V Foundation, shared a post on LinkedIn:…

Apr 14, 2025, 12:43 | Blog

Mel Mann: Never found a donor and I still became HISTORY

Mel Mann, Patient Advocate at Health Equity, Clinical Trials, Marrow Donation, shared a post on X: "It’s…

Apr 11, 2025, 07:21 | Insight

Key advances for acute myeloid leukemia in 2024 - ACS Journal Cancer

ACS Journal Cancer shared a post on X: "This commentary by Rahul Thakur and Eunice…

Apr 9, 2025, 13:35 | Blog

Coming Full Circle: Dr. Maximilian Stahl’s Inspiring Return to Yale to Lead the Fight Against Leukemia

Life often comes full circle in unexpected and meaningful ways. For Dr. Maximilian Stahl, a…

Apr 7, 2025, 10:27 | Blog

Per Ljungman: The new Recommendations from the 10th European Conference on Infections in Leukemia

Per Ljungman, Senior Physician and Hematologist at Karolinska University Hospital, shared an article on LinkedIn:…

Mar 29, 2025, 20:04 | Blog

Naveen Pemmaraju: Had a Lovely and Inspiring Dinner Event with Leukemia Clinic Team

Naveen Pemmaraju, Professor and Director of the BPDCN Program at the Department of Leukemia at…

Mar 28, 2025, 14:22 | Blog

Susanna Fletcher Greer: V Foundation researchers are making CAR T Cell therapy more effective against relapsed leukemia

Susanna Fletcher Greer, Chief Scientific Officer at the V Foundation, shared a post on LinkedIn:…

Mar 28, 2025, 11:28 | Blog

Aydah AlAwadhi: The UAE National Cancer Registry report for 2023

Aydah AlAwadhi, Assistant Professor at United Arab Emirates University, shared on LinkedIn: "Hot off the…

Mar 28, 2025, 10:50 | Blog

Julia's Brave Battle Against Leukemia: A Story of Hope and Progress - St. Baldrick's Foundation

St. Baldrick's Foundation posted on LinkedIn: "Six-year-old Julia’s bright smile can light up any room.…

Mar 11, 2025, 07:13 | Insight

Florida Leukemia Rates Rising Rapidly as Population Ages - Sylvester Comprehensive Cancer Center

Florida Leads U.S. in Leukemia Rates, But Specialized Care is Out of Reach for Some…

Feb 23, 2025, 10:22 | Blog

Tobias Neff: Mechanistic insight why stem-cell like leukemia has such poor outcomes

Tobias Neff, Executive Medical Director at Merck, shared an article by Fatemeh Alikarami, et al.…

Feb 12, 2025, 07:49 | Societies

Insights from The Lymphoma, Leukemia and Myeloma Winter Symposium

The inaugural LL&M Winter Symposium, a flagship event of the Lymphoma, Leukemia & Myeloma Congress,…

Feb 9, 2025, 16:27 | Blog

Fadi Haddad: Great time spent at the LLM 2025 meeting

Fadi Haddad, Assistant Professor at The University of Texas MD Anderson Cancer Center, posted on…

Feb 4, 2025, 16:37 | Science

Eirini Papapetrou: Our new review article on leukemia stem cells

Eirini Papapetrou, Director of the Center for the Advancement of Blood Cancer Therapies at Icahn…

Feb 1, 2025, 13:01 | Dialogues

A chat about e-cigarettes and the tobacco industry with Dr Sophie Braznell and Neil Ranasinghe

In this episode of OncoDaily Articles, Neil Ranasinghe speaks to Dr. Sophie Braznell, Research Associate…

Jan 29, 2025, 18:25 | Stories

The Mel Mann Story: From Terminal Cancer to 30 Year Survivor

Mel Mann, Patient Advocate at Health Equity, Clinical Trials, Marrow Donation, shared on LinkedIn: "The…

Jan 15, 2025, 07:53 | Blog

Moses Echodu: Recounting 2024 and Looking at 2025 - Growth and Acceleration

Moses Echodu, Chief Executive Director at Uganda Child Cancer Foundation, shared a post on LinkedIn:…

Jan 8, 2025, 17:18 | Insight

Rahul Banerjee: Cool updates about T-cell LGL leukemia needing treatment by Christina Poh

Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared…

Jan 6, 2025, 19:32 | Blog

The IACH's upcoming webinar on MRD in Acute Lymphoblastic Leukemia

The International Academy for Clinical Hematology (IACH) shared a post on X: "Don’t miss The…

Jan 6, 2025, 14:52 | Blog

E.Senthil Kumar: From Shadows to Solutions - The Revolution Against Cancer

E.Senthil Kumar, Medical Oncologist at Red Hills, Chennai, shared a post on X: "From Shadows…

Jan 3, 2025, 16:17 | Science

Iannis Aifantis: Our short review/discussion of the Comazzetto and Morrison Ascorbate deficiency

Iannis Aifantis, Chairman of the Department of Pathology at NYU School of Medicine, shared a…

Jan 3, 2025, 13:31 | Insight

Mitochondrial DNA's Role in Leukemia Development Explored by St. Jude Scientists

Mitochondrial DNA (mtDNA), typically associated with energy production in cells, has long been recognized as…

Dec 29, 2024, 11:50 | Blog

Wafaa M Rashed: Reflecting on 2024 - A Year of Learning, Growth, and Community

Wafaa M Rashed, Founder of MicroRNA Childhood Cancer Catalog (M3Cs) and Lecturer at Faculty of…

Dec 27, 2024, 18:27 | Blog

A CRISPR-based rapid molecular diagnostic for two forms of leukemia - Dana-Farber Cancer Institute

Dana-Farber Cancer Institute shared a post on LinkedIn: "Researchers at Dana-Farber have created a CRISPR-based…

Dec 24, 2024, 13:45 | Science

Naveen Pemmaraju: Transfusions with rare antibody profiles during leukemia management

Naveen Pemmaraju, Director of BPDCN Program at the Department of Leukemia at the University of…

Dec 24, 2024, 08:02 | Science

Harinder Gill: Arsenic Trioxide in newly-diagnosed Acute Promyelocytic Leukemia patients

Harinder Gill, Clinical Associate Professor in Haematology at HKU Medicine, shared a post on X:…

Dec 22, 2024, 17:07 | Blog

Rahul Shah: A great 6 months of dose-dense learning in leukemia clinic at MD Anderson Cancer Center

Rahul Shah, Hematology/Oncology Fellow at MD Anderson Cancer Center, posted on X: "A great 6…

Dec 21, 2024, 07:05 | Science

Naseema Gangat: Practical prognostic tool for the current standard of care in older/unfit AML

Naseema Gangat reshared a post by Vincent Rajkumar, Professor of Medicine at the Mayo Clinic…

Dec 20, 2024, 06:53 | Science

Nathan Punwani: The cost-effectiveness of TKI’s used in chronic myeloid leukemia

Nathan Punwani, Blood and Marrow Transplant Physician at Mayo Clinic, shared a post on LinkedIn,…

Dec 19, 2024, 12:23 | Science

ASH: Triplet combination regimens demonstrate high response rates in multiple leukemias

Three clinical trials yield strong results with undetectable measurable residual disease and overall response rates…

Dec 14, 2024, 13:33 | Blog

Sylvester Comprehensive Cancer Center names Lauren Whitmore as AVP and Associate Director for Research Administration

Sylvester Comprehensive Cancer Center shared a post on LinkedIn: "Join us in congratulating Lauren Ashley…

Dec 12, 2024, 14:22 | Blog

Fadi Haddad: Happy to present data on the role of inotuzumab in patients with B-ALL at ASH24

Fadi Haddad, Assistant Professor in the Department of Leukemia at the Division of Cancer Medicine…

Dec 8, 2024, 04:20 | Insight

Amer Zeidan: Global Disparities in Characteristics and Outcomes of Leukemia Clinical Trials

Amer Zeidan, Associate Professor of Medicine at Yale University, shared an article by Abdulrahman Alhajahjeh on…

Dec 5, 2024, 07:28 | Blog

Wafik S. El-Deiry: Dr. Yiqun Zhang’s visit to Brown University

Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director…

Dec 4, 2024, 23:06 | Blog

Let's turn belief into action today! - Leukemia and Lymphoma Society

The Leukemia and Lymphoma Society made the following post on LinkedIn: "Let's turn belief into action…

Dec 4, 2024, 18:01 | Blog

Long-term follow-up for patients with APL

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…

Dec 3, 2024, 05:36 | Insight

Real-world outcomes of commercial tisagenlecleucel for AYA

Mostafa Faisal, Adjunct Assistant Professor at Alfaisal University, shared a recent article by Itaru Kato on…

Dec 1, 2024, 22:10 | Blog

Promising Outcomes in APL Treatment - ACS Journal Cancer

ACS Journal Cancer posted the following on X: “Just published! Explore the encouraging long-term outcomes…

Nov 27, 2024, 17:51 | Drugs

FDA Approves Oral Liquid Imatinib for Leukemia and Other Cancer Treatments

The FDA has approved the first oral liquid formulation of imatinib (Imkeldi) for treating certain…

Nov 24, 2024, 18:21 | Cancer Types

Leukemia: Symptoms, Causes, Types, Diagnosis & Treatment

Leukemia is a cancer of the blood and bone marrow characterized by the uncontrolled production…

Nov 12, 2024, 14:54 | Dialogues

Beyond the Cancer Diagnosis: Dialogue with Clarissa Schilstra, Hosted by Adrian Pogacian

In the recent episode of ‘Beyond the Cancer Diagnosis’, Adrian Pogacian highlights the Psychosocial impact…

Nov 10, 2024, 16:55 | Blog

A Teen’s Story of Hope and Support from The Leukemia and Lymphoma Society

The Leukemia & Lymphoma Society posted the following on X: “'Fast forward two years, I…

Nov 9, 2024, 09:13 | Dialogues

The Global Power of Oncology Nursing (GPON) - Neil Ranasinghe's chat with Myrna Doumit and Annie Young

“We speak the language of nurses, for nurses, by nurses” In the first series of…

Oct 31, 2024, 12:11 | Blog

Richi House welcomed a new cohort of leukemia patients, survivors, and their families

Richi Childhood Cancer Foundation shared on LinkedIn: "This weekend, the Richi House welcomed a wonderful…

Oct 22, 2024, 16:54 | Blog

William D. Marrero: I’ve been accepted into the Leukemia fellowship at the MD Anderson Cancer Center

William D. Marrero, Hematology-Oncology Fellow at San Juan City Hospital, shared a post on X:…

Oct 22, 2024, 12:17 | Blog

Kelly Meza: Grateful to receive recognition as Best Lymphoma Abstract at the Leukemia, Lymphoma and Myeloma Congress

Kelly Meza, Research Assistant at Dana-Farber Cancer Institute, recently shared a post on X: “I’m…

Oct 8, 2024, 14:00 | Blog

Yan Leyfman: 2 weeks until the Lymphoma, Leukemia and Myeloma Congress

Yan Leyfman shared a post on LinkedIn: "Just 2 weeks until I'm attending the Lymphoma, Leukemia…

Oct 6, 2024, 12:48 | Insight

Yu-Hung Wang: Our latest myelofibrosis research

Yu-Hung Wang, PhD student at The University of Manchester, shared a post on X about…

Oct 4, 2024, 16:12 | Blog,Opinion

AIEOP - Biggest event of the year is here

AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) shared a post on LinkedIn: '' AIEOP’s biggest event…

Oct 4, 2024, 14:27 | Blog

Day 2 Recap of AIEOP'S 2024 Congress

AIEOP shared a post on LinkedIn: "DAY 2 RECAP OF AIEOP'S 2024 CONGRESS and DAY 1…

Sep 30, 2024, 13:38 | Career

Alex Bataller: I’m starting a new position as Assistant Professor at MD Anderson

Alex Bataller shared on LinkedIn: "I’m happy to share that I’m starting a new position…

Sep 29, 2024, 06:08 | Positive

Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024

As September, Childhood Cancer Awareness Month winds down, we reflect on it by recognizing and…

Sep 24, 2024, 12:50 | Dialogues

60 +1 Questions About Acute Lymphoblastic Leukemia in Children with Scott Howard

Professor Scott Howard is the Deputy Director at Yeolyan Hematology and Oncology Centerand the CEO…

Sep 22, 2024, 00:11 | Blog

Naveen Pemmaraju: Wonderful to spend time with our brilliant leukemia fellows

Naveen Pemmaraju shared the following on LinkedIn: “Thank you to Guillermo Garcia-Manero MD & Tapan…

Sep 21, 2024, 13:58 | Blog

OncoInfluencers to Follow on Social Media: Dr. Sanam Loghavi

We are excited to feature Dr. Sanam Loghavi as an influential figure in the oncology…

Sep 13, 2024, 23:49 | Blog

Naveen Pemmaraju: Wonderful to attend the highly successful SOHO2024 meeting

Naveen Pemmaraju posted the following on LinkedIn: “Wonderful to attend the highly successful SOHO2024 meeting held…

Sep 13, 2024, 14:17 | Opinion

Sendurai Mani: A walk to bring awareness for Cancer and early detection to save lives

Sendurai Mani shared on Linkedin: ''On September 7th, 2024, in honor of cancer survivors, to…

Sep 10, 2024, 02:28 | Blog

Supriya Peshin: Honored to meet Dr. Guillermo Garcia-Manero

Supriya Peshin, Internal Medicine Resident, Ballad Health shared a post on X: "What an honor…

Sep 10, 2024, 00:28 | Blog

Chloe’s leukemia battle: ‘My knees just gave way’ - Children’s Cancer Institute

Children’s Cancer Institute shared the following on LinkedIn: “Chloe was a happy 9-year-old who loved…

Sep 9, 2024, 13:41 | Dialogues

Dr. Vivek Subbiah on Pioneering Precision Oncology and Global Clinical Trials | OncoInfluencers #13

Dr. Vivek Subbiah, Chief of Early Phase Drug Development at Sarah Cannon Research Institute, joins…

Sep 5, 2024, 15:20 | Dialogues

Global Access and Equity in Cancer Care: Pat Garcia Gonzalez v1 | United Against Cancer

Join us for this episode of United Against Cancer, where Dr. Pat Garcia-Gonzalez, CEO of…

Aug 27, 2024, 21:35 | Blog

Tinatin Muradashvili: The role of metabolic comorbidities and viral infections in monoclonal gammopathy

Tinatin Muradashvili, Hematology and Oncology Fellow at Emory University, shared a post on X about…

Aug 23, 2024, 13:00 | Blog

OncoInfluencers to Follow on Social Media: Dr. Natalia Baran

We are excited to introduce Dr. Natalia Baran, a leading expert in leukemia research, as…

Aug 20, 2024, 14:29 | Blog

Rahul Banerjee: What's the best unifying term for the equivalent of bridging therapy but before apheresis?

Rahul Banerjee shared a poll on X: "Maybe more of a CAR-T consensus here than…

Aug 18, 2024, 13:57 | Blog

Oncoinfluencers to Follow on Social Media: Dr. Katy Rezvani

We are excited to spotlight Dr. Katy Rezvani, a prominent figure in the oncology community,…

Aug 14, 2024, 07:20 | Drugs

Keith W Pratz: Novel risk signature for AML treated with Azacitidine and Venetoclax

Keith W Pratz, Director of Leukemia at the Hospital of University of Pennsylvania, shared on…

Aug 13, 2024, 13:50 | Insight

Fieke Hoff: The need for a refined risk stratification model for older patients with AML

Fieke Hoff, Clinical hematology/oncology fellow at NIH NHLBI, shared on X: "Excited to share our…

Aug 12, 2024, 13:32 | Insight

Erman Akkus: Which cancers are most frequently diagnosed in males aged 15-34 worldwide?

Erman Akkus, Medical Oncologist at Ankara University, shared on X: "Which cancers are most frequently…

Aug 8, 2024, 10:47 | Blog

Seattle Children's named their newest research building, Building Cure, in honor of B. Wayne Hughes

Seattle Children's posted on LinkdedIn: "Today, we named our newest research building, Building Cure, in…

Aug 5, 2024, 05:34 | Dialogues

Unlocking the Immune System: Dr. Levisetti on Cue Biopharma's New Biologics

Matteo Levisetti, M.D is chief medical officer of CUE Biopharma which is a clinical-stage biopharmaceutical…

Aug 1, 2024, 04:27 | Blog

The Leukemia and Lymphoma Society: "I wanted to be that light for other teenagers" - Georgia

The Leukemia and Lymphoma Society shared on X: " 'I wanted to be that light…

Jul 31, 2024, 11:52 | Insight

Ajay Major: PFS benefit in AMPLIFY Phase III trial in CLL

Ajay Major, Lymphoma Faculty at the CU School of Medicine, shared on X: "Press release…

Jul 30, 2024, 13:25 | Insight

David Fajgenbaum: Untold story of a drug initially approved for Castleman Disease that saved a young girl's life

David Fajgenbaum shared on X: "Did you know that a repurposed drug saved the most…

Jul 30, 2024, 13:23 | Insight

Treatment of CML in pregnant patients and patients who are breastfeeding

FDA Oncology shared on X: An expert panel convened by FDA provides perspectives on drug…

Jul 30, 2024, 07:14 | Blog

Naveen Pemmaraju: Superb clinic and research teams working together in Team Pemm clinic

Naveen Pemmaraju shared a post on X: "Superb clinic and research teams working together in…

Jul 29, 2024, 02:07 | Blog

Riccardo Braglia's cancer survivorship story - Conquer Cancer

Conquer Cancer shared on LinkedIn: "Riccardo Braglia has been personally affected by cancer three times…

Jul 28, 2024, 15:35 | Societies

Uma Borate: Celebrating the hard work of the hematology community with a Bollywood theme at ASH24

Uma Borate, Acute Leukemia Clinical Section Head and Research Director at James Cancer Hospital shared…

Jul 26, 2024, 13:51 | Blog

Oncoinfluencers to Follow on Social Media: Dr. Naveen Pemmaraju

We are excited to feature Dr. Naveen Pemmaraju, a prominent expert in the field of…